Evaluation of the EasyScreen™ Pan-Enteric Pathogen Detection Kit as a Replacement for a Laboratory-Developed Gastrointestinal PCR Test

Evaluation of the EasyScreen™ Pan-Enteric Pathogen Detection Kit as a Replacement for a Laboratory-Developed Gastrointestinal PCR Test Presented at the NSCMID 2026 Conference, 27–30 August 2026, Copenhagen, Denmark Authors:  Christian Leo-Hansen1, Inger Stride Jensen1, Sarah Paulsen1, Michael Pedersen1, Ingrid Maria Cecilia Rubin1,2, and Jan Gorm Lisby1,2. Affiliations: 1Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre,…

Read More

Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia

Publication

Emerging Infectious Diseases – 2025, 31, 8.  Nicolas M. Legrand, Rowena A. Bull, Behzad Hajarizadeh, Andrew R. Lloyd, Kirsty Johnston, Katya Issa, Christine Harvey, Alicia Arnott, Dominic E. Dwyer, Vitali Sintchenko, Luke Grant, Gregory J. Dore, John Kaldor, Marianne Martinello Abstract: Limited surveillance data have hindered understanding of SARS-CoV-2 transmission within prisons. We integrated routine…

Read More

Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study

Publication

Lancet Microbe 2025; 6: 101019 ESGMAC MAPS study group Abstract: Background: Mycoplasma pneumoniae is a major cause of respiratory tract infections. We aimed to investigate the spatiotemporal dynamics, antimicrobial resistance, and severity of the delayed re-emergence of infections with M pneumoniae after the implementation of non-pharmaceutical interventions (NPIs) against COVID-19. Methods:Epidemiological data (positive and total…

Read More

Diagnosis of Viral Families Using Nucleic Acid Simplification Technique

resource thumbnail 732x394 feb23

By Dr. Douglas Millar and Dr. John Melki From the edited volume Dengue Fever in a One Health Perspective – Latest Research and Recent Advances published by IntechOpen, January 19th, 2023 Abstract We have developed a novel strategy to simplify microbial nucleic acids termed 3base™. This technology uses the chemical sodium bisulphite to reduce the…

Read More

Validation of Saliva Samples with the EasyScreen™ 3base™ SARS-CoV-2 Detection Kit (RP012)

The need for accurate SARS-CoV-2 testing remains a priority. While nasopharyngeal (NP) swabs and PCR tests are considered the most sensitive and accurate, there is a need for simpler sample collection. Saliva has been investigated as an alternate sample type and validated in this study as a sampling method for SARS-CoV-2 detection. View our poster…

Read More

TechInvest Magazine Chats with John Melki for Their Current Magazine Issue

The article looks at our ongoing growth as an Australian biotech company and how our proprietary 3base technology has allowed us to respond to the COVID-19 pandemic, as well as accelerate global rollout of diagnostics for enterics, sexual health and a pipeline of new products. TechInvest Magazine 

Read More